Evidence map›Paper›PMID 21762158›Full record

ArticleInternational dental journal2011

In vitro effects of novel toothpaste actives on components of oral malodour.

Gary R Burnett, Abish S Stephen, Robert L Pizzey, David J Bradshaw

Open access · greenAbstract read
In one paragraph

Article in International dental journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Human Body Malodor and Deodorants: The Present and the Future.International journal of molecular sciences · 2025
    Review
  4. Article
  5. The specific biochemistry of human axilla odour formation viewed in an evolutionary context.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2020
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gary R BurnettGlaxoSmithKline Consumer Healthcare, Weybridge, Surrey, UK. gary.r.burnett@gsk.com
Abish S Stephen
Robert L Pizzey
David J Bradshaw
GlaxoSmithKline (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the efficacy of a novel toothpaste containing zinc ions and o-cymen-5-ol to reduce volatile sulfur compounds (VSCs) in in vitro models and to elucidate the mode of action for any activity observed.

methodsThree models were employed, a chemical neutralisation model to evaluate the chemical reactivity of toothpaste slurries to VSCs, a biofilm perfusion model to measure activity in an orally-relevant biofilm and a planktonic bacterial model to measure antimicrobial effects.

resultsThe models showed that zinc ions were able to react chemically with hydrogen sulfide to remove this odorous component of halitotic breath. This activity was confirmed within a complex biofilm model, with over 90% of hydrogen sulfide removed from perfusate gas by a slurry of the test toothpaste.

conclusionsThis work provides a mode of action for the clinically observed reduction in VSCs seen for up to 12 hours post brushing with this novel toothpaste.

Indexed as

BiofilmsChloridesCysteineHumansHydrogen SulfideMethioninePhenolsPlanktonPorphyromonas gingivalisToothpastesZinc CompoundsChloridesCysteineHydrogen SulfideMethionineo-cymen-5-olPhenolsToothpasteszinc chlorideZinc Compounds

Identifiers

PMID21762158
PMCPMC9374987
OpenAlexW2126090473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.